Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Brunner

Showing results (551-560 of 564) with videos related to

Pageof 57
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1987
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteersJ Nussberger, T Fasanella d'Amore, M Porchet, et al.
The New England Journal of Medicine|March 2, 1972
Essential hypertension: renin and aldosterone, heart attack and strokeH R Brunner, J H Laragh, L Baer, et al.
Journal of Cardiovascular Pharmacology|September 1, 1991
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humansE Camenzind, J Nussberger, L Juillerat, et al.
Journal of Clinical Pharmacology|February 1, 1979
Effect of nadolol in treatment of hypertensionL Volicer, C S Liang, H Gavras, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521): disposition in manE H Ulm, M Hichens, H J Gomez, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteersJ P Bussien, J Biollaz, B Waeber, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS)F R Bühler, G Berglund, O K Anderson, et al.
The New England Journal of Medicine|May 4, 1978
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in manH Gavras, H R Brunner, G A Turini, et al.
Circulation|April 1, 1991
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and IIY Christen, B Waeber, J Nussberger, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin systemJ Biollaz, J L Schelling, B Jacot Des Combes, et al.
Pageof 57

Showing results (551-560 of 564) with videos related to

Sort By:
Pageof 57
Journal of Cardiovascular Pharmacology|January 1, 1987
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteersJ Nussberger, T Fasanella d'Amore, M Porchet, et al.
The New England Journal of Medicine|March 2, 1972
Essential hypertension: renin and aldosterone, heart attack and strokeH R Brunner, J H Laragh, L Baer, et al.
Journal of Cardiovascular Pharmacology|September 1, 1991
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humansE Camenzind, J Nussberger, L Juillerat, et al.
Journal of Clinical Pharmacology|February 1, 1979
Effect of nadolol in treatment of hypertensionL Volicer, C S Liang, H Gavras, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521): disposition in manE H Ulm, M Hichens, H J Gomez, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteersJ P Bussien, J Biollaz, B Waeber, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS)F R Bühler, G Berglund, O K Anderson, et al.
The New England Journal of Medicine|May 4, 1978
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in manH Gavras, H R Brunner, G A Turini, et al.
Circulation|April 1, 1991
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and IIY Christen, B Waeber, J Nussberger, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin systemJ Biollaz, J L Schelling, B Jacot Des Combes, et al.
Pageof 57